Johannes W Bigenzahn

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Nature chemical biology

Science (New York, N.Y.)

CeMM Research Center for Molecular Medicine

Medical University of Vienna (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CeMM Research Center for Molecular Medicine

Austria

PostDoc :: Giulio Superti-Furga laboratory

Education History

Medical University of Vienna

Austria

PHD

Publications

Leonhard X Heinz, JangEun Lee, Utkarsh Kapoor, Felix Kartnig, Vitaly Sedlyarov, Konstantinos Papakostas, Adrian César-Razquin, Patrick Essletzbichler, Ulrich Goldmann, Adrijana Stefanovic, Johannes W Bigenzahn, Stefania Scorzoni, Mattia D Pizzagalli, Ariel Bensimon, André C Müller, F James King, Jun Li, Enrico Girardi, M Lamine Mbow, Charles E Whitehurst, Manuele Rebsamen, Giulio Superti-Furga
TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. Nature 581 (7808) (2020)
Johannes W Bigenzahn, Giovanna M Collu, Felix Kartnig, Melanie Pieraks, Gregory I Vladimer, Leonhard X Heinz, Vitaly Sedlyarov, Fiorella Schischlik, Astrid Fauster, Manuele Rebsamen, Katja Parapatics, Vincent A Blomen, André C Müller, Georg E Winter, Robert Kralovics, Thijn R Brummelkamp, Marek Mlodzik, Giulio Superti-Furga
LZTR1 is a regulator of RAS ubiquitination and signaling. Science (New York, N.Y.) 362 (6419) (2018)
Gregory I Vladimer, Berend Snijder, Nikolaus Krall, Johannes W Bigenzahn, Kilian V M Huber, Charles-Hugues Lardeau, Kumar Sanjiv, Anna Ringler, Ulrika Warpman Berglund, Monika Sabler, Oscar Lopez de la Fuente, Paul Knöbl, Stefan Kubicek, Thomas Helleday, Ulrich Jäger, Giulio Superti-Furga
Global survey of the immunomodulatory potential of common drugs. Nature chemical biology 13 (6) (2017)